News archives 2020

Home > Author Archive

2020.10.23

NBHL will participate in BIO-Europe 2020 – Digital.

NBHL will participate in BIO-Europe 2020 – Digital to be held from October 26th to 29th, 2020. We are looking forward to meeting you in virtual partnering meetings to discuss future opportunities on our antibody technology and development pipeline. 

For more information on this event, please visit https://ebdgroup.knect365.com/bioeurope/

 

2020.10.14

NBHL will be present at BioJapan 2020 in Yokohama, Japan

NBHL will have a panel exhibition at C-13 (in Hokkaido & Sapporo Bio Consortium booth) in “BioJapan 2020” to be held in Pacifico Yokohama, Japan, from October 14th to 16th, 2020. We are looking forward to meeting you via online one-on-one partnering.

For more information on this event, please visit https://www.ics-expo.jp/biojapan/en/

2020.09.18

NBHL will participate in BioPharm America 2020 – Digital

NBHL will participate in BioPharm America 2020 – Digital to be held from September 21st to 24th, 2020. We are looking forward to meeting you in virtual partnering meetings to discuss future opportunities.

For more information on this event, please visit https://informaconnect.com/biopharm-america/

NBHL will attend Discovery on Target 2020 – Virtual.

NBHL will participate in “Discovery on Target 2020 – Virtual” to be held from September 16th to 18th, 2020. Kiyoshi Takayama (President, NBHL) will make a poster presentation on the single cell-based technology for screening and profiling of the anti-GPCR antibodies.

NB Health Laboratory Co. Ltd.

Poster #10. “Discovery of the Therapeutic mAbs Targeting GPCRs with a Unique Single Cell Analysis Technique and mAb Profiling System”

For more information on this event, please visit https://www.discoveryontarget.com/

2020.08.17

NBHL will participate in ChinaBio Partnering Forum 2020 – Digital

NBHL will participate in ChinaBio Partnering Forum 2020 – Digital to be held from August 25th to 27th, 2020. We are looking forward to meeting you in virtual partnering meetings to discuss future opportunities.

For more information on this event, please visit https://informaconnect.com/chinabio-partnering-forum-virtual/

2020.04.22

No opposition filed against NBHL’s European patent for anti-CCR7 antibodies

We are informed by European Patent Office that on expiry of the opposition period no notice of opposition has been filed against the NBHL’s European patent for anti-CCR7 antibodies granted in 2019. 

Title of the invention: Anti-human CCR7 antibodies, hybridoma, medical composition, and antibody-immobilized carrier

Patent number: EP 2 623 592

Application number: 11829086.5

Proprietor: NB Health Laboratory Co. Ltd.

 CCR7 is a GPCR involved in the pathogenesis of fibrosis and cancer. We will continue to proceed with the development of therapeutic anti-CCR7 antibodies.

2020.02.24

NBHL announces poster presentation at Antibody Engineering & Therapeutics Asia 2020 in Kyoto, Japan

Kiyoshi Takayama (President, NBHL) will have a poster presentation at Antibody Engineering & Therapeutics Asia 2020 to be held in The Westin Miyako Kyoto, Japan, from February 24th to 26th, 2020. Our presentation will focus on the new MoGRAA® discovery engine powered by the innovative high-throughput single-cell technology RiGRASSTM for discovering functional anti-GPCR antibodies. Please stop by our poster, and we look forward to meeting you to discuss future collaboration opportunities.

 

[URL]

https://informaconnect.com/antibody-engineering-therapeutics-asia/

 

2020.02.06

NBHL will attend BIO CEO & Investor Conference 2020 in New York, USA

NBHL will be at the BIO CEO & Investor Conference 2020 to be held in New York from February 10th to 11th, 2020. NBHL’s Business Development team will attend this exciting event. We are looking forward to meeting you in New York to discuss future opportunities.

 

For more information on this event, please visit https://www.bio.org/events/bio-ceo-investor-conference

2019.12.06

NBHL to present at Antibody Engineering & Therapeutics 2019 in San Diego, USA

Kiyoshi Takayama (President, NBHL) will give a presentation at Antibody Engineering & Therapeutics 2019 to be held in San Diego, USA, from December 9th to 13th, 2019. His talk will focus on the innovative high-throughput single-cell technology RiGRASSTM for the discovery of functional anti-GPCR antibodies.

 [Date of Presentation]

 December 11th, 2019 (2:55 pm – 3:25 pm)

 [Venue]

 Marriott Marquis San Diego

 [Session]

 Track 1: Emerging Technologies and Approaches for Antibody Engineering

 [Presentation Title]

 Discovery of Therapeutic Functional mAbs Targeting GPCR with a Unique Single Cell Analysis Technique

 [URL]

 https://lifesciences.knect365.com/antibody-engineering-therapeutics/

2019.11.08

NBHL will attend BIO-Europe 2019 in Hamburg, Germany.

NBHL will be at “BIO-Europe 2019” to be held in Hamburg, Germany, from November 11th to 13th, 2019. Kiyoshi Takayama (President, NBHL) and our Business Development team will attend this exciting event and would like to meet you there.

For more information on this event, please visit https://ebdgroup.knect365.com/bioeurope/

Next »